Sweden

Shares in Cellink, the Swedish maker of 3D printing equipment for the life sciences industry, rose more than 4% on Thursday morning after the company completed a Skr946m ($109.2m) growth capital raising, amid strong investor appetite for exposure to the healthcare sector due to the global Covid-19 pandemic.

Two agencies were out with dollar mandates on Monday and more public sector borrowers could follow with deals this week as a rise in US Treasury yields boosts demand for SSA dollar bonds.

The Inter-American Development Bank (IADB) broke the silence in the SSA market with a Canadian dollar sustainable development bond. The deal shared the market with a dollar trade from Kommuninvest, with both issuers steering clear of the almost dormant euro market.

Subordinated bond issuance could decline dramatically among Nordic banks following implementation the EU’s new bank recovery and resolution directive (BRRD 2), Fitch said this week.

Trading levels given are bid-side spreads versus mid-swaps and/or an underlying benchmark and bid-yields from the close of business on Monday, July 27. The source for secondary trading levels is ICE Data Services.

This week's scorecard looks at the progress Nordic agencies have made in their 2020 funding programmes in late July.

Swedish Export Credit Corporation kept the public sector new issues market open on Thursday as it came with an opportunistic four year dollar trade on the back of a strong week for dollar borrowers.

Smaller loan loss provisions and high capital ratios have helped Nordic lenders to kick off European bank earnings season in a positive fashion. But analysts are cautious about drawing any conclusions for the rest of the sector.

Richard Livingstone, the British billionaire property developer, sold Skr5.5bn ($616m) of shares in Swedish online gambling company Evolution Gaming in an overnight trade on Monday, to help mitigate the effect of Covid-19 on his property portfolio.

Swedish social housing manager Samhällsbyggnadsbolaget i Norden (SBB) has issued a Sk2.75bn (€270m) mandatory convertible bond to shore up its balance sheet as it pursues further investment opportunities in the social infrastructure space.

The Swedish National Debt Office has selected the maturity range for its debut green bond and the banks that will lead the transaction, which will take place via syndication in August.

Hansa Biopharma, the Swedish pharmaceuticals company, raised Skr1.1bn ($121m) through a sale of new shares on Wednesday evening to fund the launch of a new drug for patients undergoing kidney transplants.